Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air

Journal of Microbiological Methods

Volumn 81, Issue 2, 2010, Pages 197-199

  Vanhee, Lies M E ^a   Perman, Dana ^a   Nelis, Hans J ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Air sampling; Aspergillus; Itraconazole resistance; Solid phase cytometry

Indexed keywords

ITRACONAZOLE;

AIR SAMPLING; AIRBORNE PARTICLE; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; COLONY FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOMETRY; FUNGAL CELL CULTURE; FUNGAL DETECTION; FUNGUS ISOLATION; HIGH THROUGHPUT SCREENING; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLATE COUNT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE CYTOMETRY;

AIR MICROBIOLOGY; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, FUNGAL; HUMANS; ITRACONAZOLE; MYCOLOGY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

EID: 77951954182     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2010.02.012     Document Type: Article

References (12)

1. Arauja R., Pina-Vaz C., Rodrigues A.G. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int. J. Antimicrob. Agents 2007, 29:108-111.
2. Chryssanthou E. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole. Scand. J. Infect. Dis. 1997, 29:509-512.
3. Dannaoui E., Persat F., Monier M.F., Borel E., Piens M.A., Picot S. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J. Antimicrob. Chemother. 1999, 44:553-555.
4. Gomez-Lopez A., Garcia-Effron G., Mellado E., Monzon A., Rodriguez-Tudela J.L., Cuenca-Estrella M. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 2003, 47:3085-3088.
5. Guinea J., Peláez T., Alcalá L., Ruiz-Serrano M.J., Bouza E. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob. Agents Chemother. 2005, 49:3495-3497.
6. Meneau I., Sanglard D. Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. Med. Mycol. 2005, 43:S307-S311.
7. Rodriguez-Tudela J.L., Alcazar-Fuoli L., Mellado A., Alastruey-Izquierdo A., Monzon A., Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 2008, 52:2468-2472.
8. Snelders E., van der Lee H.A.L., Kuijpers J., Rijs A.J.M.M., Varga J., Samson R.A., Mellado E., Donders A.R.T., Melchers W.J.G., Verweij P.E. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008, 5:1629-1637.
9. Snelders E., Huis in 'tVeld R.A.G., Rijs A.J.M.M., Kema G.H.J., Melchers W.J.G., Verweij P.E. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl. Environ. Microbiol. 2009, 75:4053-4057.
10. Vanhee L.M.E., Nelis H.J., Coenye T. Rapid detection and quantification of Aspergillus fumigatus in environmental air samples using solid-phase cytometry. Environ. Sci. Technol. 2009, 43:3233-3239.
11. Verweij P.E., Mensink M., Rijs A.J.M.M., Donnelly J.P., Meis J.F.G.M., Denning D.W. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. J. Antimicrob. Chemother. 1998, 42:389-392.
12. Verweij P.E., Te Dorsthorst D.T.A., Rijs A.J.M.M., De Vries-Hospers H.G., Meis J.F.G.M. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J. Clin. Microbiol. 2002, 40:2648-2650. The Dutch Interuniversity Working Party for Invasive Mycoses.